Article Versions Notes

Wickstroem K, Karlsson J, Ellingsen C, Cruciani V, Kristian A, Hagemann UB, Bjerke RM, Ryan OB, Linden L, Mumberg D, et al. Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model. Pharmaceuticals. 2019; 12(4):155. https://doi.org/10.3390/ph12040155

Wickstroem, Katrine, Jenny Karlsson, Christine Ellingsen, Véronique Cruciani, Alexander Kristian, Urs B. Hagemann, Roger M. Bjerke, Olav B. Ryan, Lars Linden, Dominik Mumberg, and et al. 2019. "Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model" Pharmaceuticals 12, no. 4: 155. https://doi.org/10.3390/ph12040155

Wickstroem, K., Karlsson, J., Ellingsen, C., Cruciani, V., Kristian, A., Hagemann, U. B., Bjerke, R. M., Ryan, O. B., Linden, L., Mumberg, D., Brands, M., & Cuthbertson, A. (2019). Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model. Pharmaceuticals, 12(4), 155. https://doi.org/10.3390/ph12040155